Loading
Loading…
Loading…
Tender Value
₹74,934.50
EMD Value
Exempted
Closing Date
6 Aug 2026, 9:00 am
druigs and pharmaceutical products
9663723
GEM/2026/B/7836845
Two Packet Bid
Colistin 4 point 5 million IU Inj,Dr Morepen Glucostrips pack of 50,Amikacin Sulphate 250 mg 2 ml I
Kachchh, Gujarat
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹31
₹2 L
40%
Exempted
Yes
26 Jul 2026
26 Jul 2026
6 Aug 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|---|
| 1 | Colistin 4 point 5 million IU Inj | Colistin 4 point 5 million IU Inj | 15 | Vial | KUTCHH/BHUJ | 30 | - |
| 2 | Dr Morepen Glucostrips pack of 50 | Dr Morepen Glucostrips pack of 50 | 30 | Bott | KUTCHH/BHUJ | 30 | |
| 3 | Amikacin Sulphate 250 mg 2 ml Inj | Amikacin Sulphate 250 mg 2 ml Inj | 300 | Vial | KUTCHH/BHUJ | 30 | - |
| 4 | Mupirocin 2 per Oint tube of 5 gm | Mupirocin 2 per Oint tube of 5 gm | 450 | Tube | KUTCHH/BHUJ | 30 | |
| 5 | Clobazam 5mg Tab | Clobazam 5 mg Tab | 900 | No | KUTCHH/BHUJ | 30 | |
| 6 | Dorzolamide plus Timolol bott of 5 ml | Dorzolamide 2 percent plus Timolol 0 point percent bott of 5 ml | 10 | Bottle | KUTCHH/BHUJ | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9663723.pdf
GEM_BID • 0.12 MB
drug_specification-45_2026-07-26-13-46-10_0510cde04818d7386e9a0f5cf5828070.pdf
BOQ • 0.18 MB
boq_item_sample_file_2026-07-26-13-46-10_941958b026af3b814f83db11cd356c1a.csv
BOQ • 0.00 MB
ATC_c81cd64c-3282-4f07-a5151785054054460_SaurabhKhare.docx
GEM_OTHER • 0.01 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].